{"id":"W2763004155","doi":"10.1016/j.ejca.2017.08.032","title":"Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Health Sciences Centre; Jewish General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Alcohol and Drug Abuse Institute, University of Washington; Merck","keywords":"Ipilimumab; Pembrolizumab; Medicine; Oncology; Internal medicine; Melanoma; Immunotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004794751,0.000188193,0.0006890515,0.0002439647,0.00005484463,0.0000221359,0.0002165145,0.00002204239,0.00006466044],"category_scores_gemma":[0.0001970113,0.0001267424,0.0001297176,0.0001192763,0.00008245669,0.0001981383,0.00003847944,0.000255732,8.468959e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001969606,"about_ca_system_score_gemma":0.0001754962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001441592,"about_ca_topic_score_gemma":0.0003300862,"domain_scores_codex":[0.997847,0.0002115673,0.001010096,0.0001777056,0.0005473085,0.0002063114],"domain_scores_gemma":[0.9976316,0.00005650516,0.001507052,0.0004359064,0.0002853646,0.00008355323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3084547,0.001032134,0.6333559,0.00001688559,0.0004792219,0.0003816497,0.001448942,0.00004834285,0.0002606353,1.413916e-7,0.00003536502,0.05448612],"study_design_scores_gemma":[0.3107736,0.006097987,0.6817532,0.0003153084,0.0001028667,0.000004577966,0.0003692727,0.000002195598,0.0001897813,3.628938e-7,0.0002964532,0.00009440268],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967468,0.0004561842,0.00000181048,0.0001565383,0.0005392925,0.0007204528,0.000004368405,0.000004680184,0.001369882],"genre_scores_gemma":[0.9996476,0.00009347859,0.00005496587,0.0000547775,0.00003959422,0.000007240145,0.000001182014,0.00003487841,0.00006626112],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05439172,"threshold_uncertainty_score":0.5168405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01614722972116736,"score_gpt":0.2909443206967434,"score_spread":0.274797090975576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}